Risk of early hepatocellular carcinoma recurrence following liver resection: arbitrary specification or possible target to improve outcome?
作者信息
Kornberg Arno
机构信息
Department of Surgery, Klinikum rechts der Isar, School of Medicine, Technical University of Munich, Munich, Germany.
出版信息
Hepatobiliary Surg Nutr. 2024 Aug 1;13(4):745-748. doi: 10.21037/hbsn-24-202. Epub 2024 Jul 12.
Abstract
摘要
相似文献
1
Risk of early hepatocellular carcinoma recurrence following liver resection: arbitrary specification or possible target to improve outcome?肝切除术后早期肝细胞癌复发的风险：随意设定还是改善预后的潜在靶点？
Hepatobiliary Surg Nutr. 2024 Aug 1;13(4):745-748. doi: 10.21037/hbsn-24-202. Epub 2024 Jul 12.
2
Advantage of early liver transplantation whenever indicated for hepatocellular carcinoma recurrence after primary liver resection.对于原发性肝癌切除术后肝癌复发，只要有指征，早期肝移植的优势。
Biomed J. 2019 Oct;42(5):335-342. doi: 10.1016/j.bj.2019.04.001. Epub 2019 Oct 29.
3
Impact of margin status on long-term results of liver resection for hepatocellular carcinoma: single-center time-to-recurrence analysis.肝癌肝切除术后切缘状态对长期结果的影响：单中心复发时间分析。
Updates Surg. 2020 Mar;72(1):109-117. doi: 10.1007/s13304-019-00686-5. Epub 2019 Oct 17.
4
Long-term outcomes following resection of hepatocellular adenomas with small foci of malignant transformation or malignant adenomas.伴有微小恶性转化灶的肝细胞腺瘤或恶性腺瘤切除术后的长期预后。
JHEP Rep. 2021 Jun 29;3(4):100326. doi: 10.1016/j.jhepr.2021.100326. eCollection 2021 Aug.
5
The Outcome of Salvage Liver Transplantation and Liver Resection for Recurrent Hepatocellular Carcinoma Using the 5-5-500 Rule, Japanese Extended Liver Transplantation Criteria for Hepatocellular Carcinoma.5-5-500 规则和日本扩大肝癌肝移植标准下肝切除和挽救性肝移植治疗复发性肝细胞癌的结果。
Transplant Proc. 2023 May;55(4):901-905. doi: 10.1016/j.transproceed.2023.04.028. Epub 2023 May 25.
6
LI-RADS category 5 hepatocellular carcinoma: preoperative gadoxetic acid-enhanced MRI for early recurrence risk stratification after curative resection.LI-RADS 类别 5 肝细胞癌：根治性切除术后早期复发风险分层的术前钆塞酸增强 MRI。
Eur Radiol. 2021 Apr;31(4):2289-2302. doi: 10.1007/s00330-020-07303-9. Epub 2020 Oct 1.
7
Prophylactic liver transplantation for high-risk recurrent hepatocellular carcinoma.高危复发性肝细胞癌的预防性肝移植
World J Hepatol. 2016 Nov 8;8(31):1309-1317. doi: 10.4254/wjh.v8.i31.1309.
8
Role of liver and spleen stiffness in predicting the recurrence of hepatocellular carcinoma after resection.肝脏和脾脏硬度在预测肝癌切除术后复发中的作用。
J Hepatol. 2019 Mar;70(3):440-448. doi: 10.1016/j.jhep.2018.10.022. Epub 2018 Oct 31.
9
Impact of HBsAg seroclearance on late recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection.HBsAg 血清学清除对乙型肝炎病毒相关肝细胞癌切除术后晚期复发的影响。
J Hepatol. 2022 Oct;77(4):939-946. doi: 10.1016/j.jhep.2022.05.014. Epub 2022 May 26.
10
Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation.米兰标准以外的肝细胞癌的外科治疗。肝切除、挽救性移植和原位肝移植的结果。
Ann Surg Oncol. 2008 May;15(5):1383-91. doi: 10.1245/s10434-008-9851-z. Epub 2008 Mar 5.
本文引用的文献
1
Liver transplantation vs liver resection in HCC: promoting extensive collaborative research through a survival meta-analysis of meta-analyses.肝细胞癌肝移植与肝切除术的比较：通过荟萃分析的生存荟萃分析促进广泛的合作研究。
Front Oncol. 2024 Mar 18;14:1366607. doi: 10.3389/fonc.2024.1366607. eCollection 2024.
2
Preoperative transarterial chemoembolization (TACE) + liver resection versus upfront liver resection for large hepatocellular carcinoma (≥5 cm): a systematic review and meta-analysis.术前经动脉化疗栓塞术（TACE）联合肝切除术与直接肝切除术治疗大肝细胞癌（≥5厘米）的系统评价和荟萃分析
Acta Chir Belg. 2023 Dec;123(6):601-617. doi: 10.1080/00015458.2023.2256539. Epub 2023 Sep 8.
3
Predictors and long-term prognosis of early and late recurrence for patients undergoing hepatic resection of hepatocellular carcinoma: a large-scale multicenter study.肝细胞癌肝切除患者早期和晚期复发的预测因素及长期预后：一项大规模多中心研究
Hepatobiliary Surg Nutr. 2023 Apr 10;12(2):155-168. doi: 10.21037/hbsn-21-288. Epub 2021 Oct 21.
4
Predictors of early and late hepatocellular carcinoma recurrence.预测早期和晚期肝细胞癌复发的因素。
World J Gastroenterol. 2023 Feb 28;29(8):1243-1260. doi: 10.3748/wjg.v29.i8.1243.
5
Surgical Strategies for Recurrent Hepatocellular Carcinoma after Resection: A Review of Current Evidence.肝切除术后复发性肝细胞癌的手术策略：当前证据综述
Cancers (Basel). 2023 Jan 13;15(2):508. doi: 10.3390/cancers15020508.
6
Histological Severity of Cirrhosis Influences Surgical Outcomes of Hepatocellular Carcinoma After Curative Hepatectomy.肝硬化的组织学严重程度影响根治性肝切除术后肝细胞癌的手术结局。
J Hepatocell Carcinoma. 2022 Jul 23;9:633-647. doi: 10.2147/JHC.S368302. eCollection 2022.
7
Postresection Period-Specific Hazard of Recurrence as a Framework for Surveillance Strategy in Patients with Hepatocellular Carcinoma: A Multicenter Outcome Study.肝细胞癌患者术后特定时期复发风险作为监测策略框架的多中心结局研究
Liver Cancer. 2021 Sep 17;11(2):141-151. doi: 10.1159/000518837. eCollection 2022 Apr.
8
New frontiers in liver resection for hepatocellular carcinoma.肝细胞癌肝切除术的新前沿
JHEP Rep. 2020 Jun 4;2(4):100134. doi: 10.1016/j.jhepr.2020.100134. eCollection 2020 Aug.
9
The chances of hepatic resection curing hepatocellular carcinoma.肝切除治愈肝细胞癌的几率。
J Hepatol. 2020 Apr;72(4):711-717. doi: 10.1016/j.jhep.2019.11.016. Epub 2019 Nov 30.
10
Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma: A Multicenter Study From China.中国多中心研究：肝癌切除术后晚期复发的危险因素、模式和结局。
JAMA Surg. 2019 Mar 1;154(3):209-217. doi: 10.1001/jamasurg.2018.4334.
Zotero 插件